A new aspect of tolbutamide metabolism in the rabbit: the role of 1-butyl-3-(p-formylphenyl)sulphonylurea.
K Washio, O Makaya, H Sasaki, K Nishida, J Nakamura, J Shibasaki
Index: J. Pharm. Pharmacol. 45(3) , 231-3, (1993)
Full Text: HTML
Abstract
We investigated the metabolism of tolbutamide by using synthetic 1-butyl-3-(p-formylphenyl)sulphonylurea (ATB), an intermediate in the metabolic pathway of tolbutamide. ATB (40 mg kg-1) administered intravenously to rabbits was oxidized to 1-butyl-3-(p-carboxyphenyl)sulphonylurea (CTB) and also reduced to 1-butyl-3-(p-hydroxymethylphenyl)sulphonylurea (HMTB). Therefore, it is likely that in the metabolism of tolbutamide, the oxidation of HMTB to ATB involved the reverse reaction, suggesting the reduction of ATB to HMTB. The oxidation of ATB to CTB was inhibited by disulfiram pretreatment. ATB was detected in the blood following intravenous administration of HMTB in rabbits pretreated with disulfiram. These results, confirm that ATB is an intermediate in the oxidative metabolism of tolbutamide in the rabbit.
Related Compounds
Related Articles:
2008-08-01
[J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 871(1) , 78-89, (2008)]
Cytochrome P450 2C9 phenotyping using low-dose tolbutamide.
2004-05-01
[Eur. J. Clin. Pharmacol. 60(3) , 165-71, (2004)]
1999-12-01
[Ther. Drug Monit. 21(6) , 664-71, (1999)]
Inhibition of tolbutamide elimination by cimetidine but not ranitidine.
1986-01-01
[J. Clin. Pharmacol. 26(5) , 372-7, (1986)]
Pharmacokinetics of tolbutamide in ethnic Chinese.
1999-02-01
[Br. J. Clin. Pharmacol. 47(2) , 151-6, (1999)]